Santen Pharmaceutical Co Ltd 2017 Annual Report with Sustainability Disclosures
The report describes Santen's 2017 integrated performance as a specialized global ophthalmology company, reporting record revenue of ¥199.1 billion. It highlights Japan CO2 emissions of 24,545 tons, a 30.6% reduction from fiscal 2005, and a 0.012% final waste disposal ratio. The CSR section also covers ISO 14001 environmental management, human rights, occupational health and safety, and diversity, including a 10.2% female-manager ratio in Japan.
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2017
Type: Annual Report with Sustainability Disclosures
Pages: 116
Back to company
Santen Pharmaceutical Co Ltd
Annual Report
The report describes Santen's 2017 integrated performance as a specialized global ophthalmology company, reporting record revenue of ¥199.1 billion. It highlights Japan CO2 emissions of 24,545 tons, a 30.6% reduction from fiscal 2005, and a 0.012% final waste disposal ratio. The CSR section also covers ISO 14001 environmental management, human rights, occupational health and safety, and diversity, including a 10.2% female-manager ratio in Japan.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Apr 1, 2016 - Mar 31, 2017
Fiscal Year
2017
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Women in Management
Employees